Register here
October 25, 2022 - 17:00 CEST
Learn about Cytiva's catalogue of ready-to-use engineered AAVrep/cap sequences. And we are developing a robust and scalable adeno-associated virus (AAV) manufacturing process in Sf9 cell lines using novel fiber-based affinity technology with the potential to scale from PD to manufacturing.
Webinar Learning Objectives:
AAV Manufacturing using SF9 cell lines
High yield downstream process optimization GMP ready
Learn how Cytia can support your Gene Therapy project
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.